EXPO restricted stock proposed sale reported

EXPO files a Form 144 notice reporting proposed sales of restricted common stock.

Rhea-AI Filing Summary

EXPO files a Form 144 notice reporting proposed sales of restricted common stock.

The filing lists three restricted stock lots of 594, 568 and 510 shares with grant dates 03/11/2022, 03/11/2026 and 03/12/2021

Key Figures

Restricted lot: 594 shares Restricted lot: 568 shares Restricted lot: 510 shares +4 more

7 metrics

Restricted lot 594 shares grant date 03/11/2022

Restricted lot 568 shares grant date 03/11/2026

Restricted lot 510 shares grant date 03/12/2021

Filing date 05/19/2026 date shown in header

Broker/issuer line numeric 1672 field present in issuer information

Numeric field 98062.13 field present in issuer information

Numeric field 48511629 field present in issuer information

Key Terms

Restricted Stock, Securities To Be Sold, Issuer

3 terms

Restricted Stock financial

"Common | 03/11/2022 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Issuer regulatory

"Restricted Stock | Issuer | | | 594"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does EXPO's Form 144 disclose?

It discloses proposed sales of restricted common stock by EXPO. The notice lists three lots of restricted shares: 594, 568, and 510 with corresponding grant dates shown in the filing.

Who is listed as the issuer or broker in the Form 144 for EXPO?

The filing lists Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, New York. That broker/dealer appears in the issuer/broker line of the notice as provided.

What securities and grant dates are shown in the EXPO filing?

The securities are identified as Common restricted stock with grant dates 03/11/2022, 03/11/2026, and 03/12/2021 and the listed share counts of 594, 568 and 510.

Does the Form 144 state transaction proceeds or sale timing?

The notice lists the restricted stock lots and grant dates but it does not provide price, proceeds, or a sale execution date in the excerpted lines shown in the content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 04:14 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001633078
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EXPONENT, INC.
SEC File Number	000-18655
Address of Issuer	149 COMMONWEALTH DRIVE, MENLO PARK CALIFORNIA 94025
Phone	(650) 326-9400
Name of Person for Whose Account the Securities are To Be Sold	RICHARD REISS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1672	98062.13	48511629	05/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/11/2022	Restricted Stock	Issuer			594	03/11/2022	Not Applicable
Common	03/11/2026	Restricted Stock	Issuer			568	03/11/2026	Not Applicable
Common	03/12/2021	Restricted Stock	Issuer			510	03/12/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Richard Reiss
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)